Neuren Pharmaceuticals | NEU - Ebitda

Aktienkurs
12.14
Täglich Wechseln
-0.04 -0.33%
Monatlich
1.76%
Jährlich
10.46%
Q2 Prognose
12.25




Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Avita Medical AUD -9.69M 12.21M 2025-12
Clinuvel Pharmaceuticals AUD 27.55M 12.65M 2025-06
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Genetic Signatures AUD -7.11M 970K 2024-12
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Medical Developments International AUD 1.78M 3.78M 2024-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Organon & Co USD 383M 135M 2025-12
Paradigm Biopharmaceuticals AUD -5.86M 3.79M 2024-12
PYC Therapeutics AUD -22.79M 1.5M 2025-12
Starpharma Holdings AUD -4.85M 1.73M 2024-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12
Viatris USD 1B 151.5M 2025-12
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12